Long-term health benefits of stroke prevention with apixaban versus vitamin K antagonist warfarin in patients with non-valvular atrial fibrillation in Germany: a population-based modelling study-Reference-Cited by-同舟云学术

Long-term health benefits of stroke prevention with apixaban versus vitamin K antagonist warfarin in patients with non-valvular atrial fibrillation in Germany: a population-based modelling study

Published:2018-10-08 Issue:2 Volume:19 Page:223-230
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Himmler Sebastian¹,Müller Malina¹,Ostwald Dennis¹,Seddik Ahmed¹,Basic Edin²,Hradetzky Eva³

Affiliation:

1. Health Economics, WifOR, Darmstadt, Germany

2. Health Technology Assessment & Outcomes Research, Pfizer Deutschland GmbH, Berlin, Germany

3. Medical Affairs Internal Medicine, Pfizer Pharma GmbH, Berlin, Germany

Funder

Bristol-Myers Squibb

Pfizer

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2019.1522501

Reference31 articles.

1. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients

2. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation

3. Executive Summary: Heart Disease and Stroke Statistics—2010 Update

4. Bristol-Myers Squibb/Pfizer EEIG. Fachinformation. ELIQUIS® 5 mg Filmtabletten. Bristol-Myers Squibb/Pfizer EEIG, 2012. Middlesex/UK; 2012.

5. Apixaban versus Warfarin in Patients with Atrial Fibrillation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The societal impact of obinutuzumab in the first-line treatment of patients with follicular lymphoma in Germany;Journal of Comparative Effectiveness Research;2020-10

2. Safety and Efficacy of Oral Anticoagulants Therapies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-Analysis;Journal of Cardiovascular Pharmacology and Therapeutics;2020-06-03

3. Anticoagulation in Atrial Fibrillation Patients;Epidemiology and Treatment of Atrial Fibrillation;2020-04-22

4. Patient characteristics and stroke and bleeding events in nonvalvular atrial fibrillation patients treated with apixaban and vitamin K antagonists: a Spanish real-world study;Journal of Comparative Effectiveness Research;2019-10